Aspirin May Lower Colon Cancer Risk
Score another potential benefit of a daily aspirin. According to a Danish study, people who took one or two baby aspirins a day for at least five years reduced their risk of colon cancer significantly.
The study at the Danish Cancer Society Research Center found that taking low-dose aspirin on a continuous basis for at least that long reduced the risk of colorectal cancer by 27 percent and that using nonaspirin NSAIDs (non-stereroidal anti-inflammatory drugs) like ibuprofen lowered cancer risk by 30 percent. No positive effects regarding cancer prevention were seen if these drugs were only taken intermittently.
Limitations of the study included using data for people who received prescriptions for the aspirin or NSAIDs and the data didn’t include people who made over-the-counter purchases. Additionally, researchers cannot rule out other factors that may have increased people’s risk for colorectal cancer such as family history or obesity.
The researchers emphasized, however, that no one should start a daily aspirin regimen without first talking to their doctor.
Colon cancer affects mostly people over the age of 50, according to the National Cancer Institute.
_This Week's Slice of History: _Taking on DDT: Aug. 29, 1962